Aurora A kinase as a target for therapy in <i>TCF3-HLF</i> rearranged acute lymphoblastic leukemia

• Jessica Leonard,
• Joelle SJ Wolf,
• Michelle Degnin,
• Christopher A. Eide,
• Dorian LaTocha,
• Kyle Lenz,
• Beth Wilmot,
• Charles G. Mullighan,
• Mignon Loh,
• Stephen P Hunger,
• Brian J Druker,
• Marc M Loriaux,
• Jeffrey W Tyner,
• Bill H Chang

Affiliations

Jessica Leonard

Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon

Joelle SJ Wolf

Division of Hematology and Oncology, Department of Pediatrics and OHSU Knight Cancer Institute. OHSU, Portland, Oregon

Michelle Degnin

Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon

Christopher A. Eide

Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon

Dorian LaTocha

Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon

Kyle Lenz

Division of Hematology and Oncology, Department of Pediatrics and OHSU Knight Cancer Institute. OHSU, Portland, Oregon

Beth Wilmot

Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, and OHSU Knight Cancer Institute, OHSU, Portland, Oregon

Charles G. Mullighan

Department of Pathology, St Jude Children's Research Hospital and University of Tennessee Health Science Center, Memphis, TN 38105

Mignon Loh

Department of Pediatrics, Benioff Children's Hospital, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California

Stephen P Hunger

Department of Pediatrics and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Children's Hospital of Philadelphia

Brian J Druker

Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon, USA; Investigator, Howard Hughes Medical Institute

Marc M Loriaux

Department of Pathology and OHSU Knight Cancer Institute. OHSU, Portland, Oregon

Jeffrey W Tyner

Division of Hematology and Medical Oncology, Department of Medicine and OHSU Knight Cancer Institute. OHSU, Portland, Oregon, USA; Department of Cell, Molecular, and Cancer Biology, and OHSU Knight Cancer Institute, OHSU, Portland, Oregon

Bill H Chang

Division of Hematology and Oncology, Department of Pediatrics and OHSU Knight Cancer Institute. OHSU, Portland, Oregon